Continuous Intravenous Administration of Ketorolac Reduces Pain and Morphine Consumption After Total Hip or Knee Arthroplasty
| Autor: | R. C. Etches, D. N. Buckley, V. W. S. Chan, N. Badner, W. S. Beattie, C. B. Warriner, M. Girard, D. Parsons |
|---|---|
| Rok vydání: | 1995 |
| Předmět: |
Male
medicine.medical_specialty Consciousness medicine.medical_treatment Analgesic Postoperative Hemorrhage Placebo law.invention Placebos Bolus (medicine) Double-Blind Method Randomized controlled trial law medicine Humans Hypnotics and Sedatives Prospective Studies Tolmetin Infusions Intravenous Aged Pain Measurement Pain Postoperative Morphine business.industry Analgesia Patient-Controlled Analgesics Non-Narcotic Middle Aged Arthroplasty Surgery Analgesics Opioid body regions Ketorolac Anesthesiology and Pain Medicine Tolerability Anesthesia Injections Intravenous Antiemetics Female Hip Prosthesis Analgesia Knee Prosthesis business medicine.drug |
| Zdroj: | Anesthesia & Analgesia. 81:1175-1180 |
| ISSN: | 0003-2999 |
| Popis: | The purpose of this study was to determine the analgesic efficacy, opioid-sparing effect, and tolerability of ketorolac administered as an intravenous (i.v.) bolus followed by a continuous infusion after total hip or knee arthroplasty. After general anesthesia, patients received either placebo or ketorolac 30 mg i.v. as a bolus over 15-30 s followed by a continuous i.v. infusion of ketorolac 5 mg/h for 24 h. All patients received patient-controlled i.v. morphine with no background infusion. Patients were assessed at 2, 4, 6, and 24 postoperatively with respect to analgesia, morphine consumption, side effects, and blood loss. Patients receiving ketorolac reported were less sedated and required fewer antiemetics. There was no difference in blood loss. Patients receiving ketorolac reported better analgesia and used less morphine (35% for hips and 44% for knees) than those receiving placebo. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|